Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 398

1.

Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism.

Weitz JI, Lensing AWA, Prins MH, Bauersachs R, Beyer-Westendorf J, Bounameaux H, Brighton TA, Cohen AT, Davidson BL, Decousus H, Freitas MCS, Holberg G, Kakkar AK, Haskell L, van Bellen B, Pap AF, Berkowitz SD, Verhamme P, Wells PS, Prandoni P; EINSTEIN CHOICE Investigators..

N Engl J Med. 2017 Mar 30;376(13):1211-1222. doi: 10.1056/NEJMoa1700518. Epub 2017 Mar 18.

PMID:
28316279
2.
3.

Pulmonary Embolism in Patients Hospitalized for Syncope.

Prandoni P, Lensing AWA, Prins MH.

N Engl J Med. 2017 Feb 2;376(5):497. doi: 10.1056/NEJMc1615913. No abstract available.

4.

Choosing wisely: The impact of patient selection on efficacy and safety outcomes in the EINSTEIN-DVT/PE and AMPLIFY trials.

Beyer-Westendorf J, Lensing AW, Arya R, Bounameaux H, Cohen AT, Wells PS, Middeldorp S, Verhamme P, Hughes R, Kucher N, Pap AF, Trajanovic M, Prins MH, Prandoni P, Weitz JI.

Thromb Res. 2017 Jan;149:29-37. doi: 10.1016/j.thromres.2016.11.014. Epub 2016 Nov 21.

PMID:
27886530
5.

Prevalence of Pulmonary Embolism among Patients Hospitalized for Syncope.

Prandoni P, Lensing AW, Prins MH, Ciammaichella M, Perlati M, Mumoli N, Bucherini E, Visonà A, Bova C, Imberti D, Campostrini S, Barbar S; PESIT Investigators..

N Engl J Med. 2016 Oct 20;375(16):1524-1531.

6.

Symptomatic abdominal aortic aneurysm repair: to wait or not to wait.

Ten Bosch JA, Koning SW, Willigendael EM, VAN Sambeek MR, Stokmans RA, Prins MH, Teijink JA.

J Cardiovasc Surg (Torino). 2016 Dec;57(6):830-838. Epub 2013 Jul 18.

PMID:
23867861
7.

Post-thrombotic syndrome in patients treated with rivaroxaban or enoxaparin/vitamin K antagonists for acute deep-vein thrombosis. A post-hoc analysis.

Cheung YW, Middeldorp S, Prins MH, Pap AF, Lensing AW, Ten Cate-Hoek AJ, Villalta S, Milan M, Beyer-Westendorf J, Verhamme P, Bauersachs RM, Prandoni P; Einstein PTS Investigators Group..

Thromb Haemost. 2016 Sep 27;116(4):733-8. doi: 10.1160/TH16-01-0041. Epub 2016 Sep 1.

PMID:
27583311
8.

Treatment of venous thromboembolism with rivaroxaban in relation to body weight. A sub-analysis of the EINSTEIN DVT/PE studies.

Di Nisio M, Vedovati MC, Riera-Mestre A, Prins MH, Mueller K, Cohen AT, Wells PS, Beyer-Westendorf J, Prandoni P, Bounameaux H, Kubitza D, Schneider J, Pisters R, Fedacko J, Fontes-Carvalho R, Lensing AW.

Thromb Haemost. 2016 Sep 27;116(4):739-46. doi: 10.1160/TH16-02-0087. Epub 2016 Aug 18.

PMID:
27535349
9.

The impact of a male or female thrombotic family history on contraceptive counseling: a cohort study.

van Vlijmen EF, Veeger NJ, Middeldorp S, Hamulyák K, Prins MH, Kluin-Nelemans HC, Meijer K.

J Thromb Haemost. 2016 Sep;14(9):1741-8. doi: 10.1111/jth.13393. Epub 2016 Aug 11.

PMID:
27327043
10.

Long-term Anticoagulation With Rivaroxaban for Preventing Recurrent VTE: A Benefit-Risk Analysis of EINSTEIN-Extension.

Wells PS, Prins MH, Levitan B, Beyer-Westendorf J, Brighton TA, Bounameaux H, Cohen AT, Davidson BL, Prandoni P, Raskob GE, Yuan Z, Katz EG, Gebel M, Lensing AW.

Chest. 2016 Nov;150(5):1059-1068. doi: 10.1016/j.chest.2016.05.023. Epub 2016 Jun 1.

PMID:
27262225
11.

Erratum to: 'Oral rivaroxaban for Japanese patients with symptomatic venous thromboembolism - the J-EINSTEIN DVT and PE program'.

Yamada N, Hirayama A, Maeda H, Sakagami S, Shikata H, Prins MH, Lensing AW, Kato M, Onuma J, Miyamoto Y, Iekushi K, Kajikawa M.

Thromb J. 2016 May 23;14:11. doi: 10.1186/s12959-016-0085-1. eCollection 2016.

12.

Post-thrombotic syndrome and the risk of subsequent recurrent thromboembolism.

Prandoni P, Noventa F, Lensing AW, Prins MH, Villalta S.

Thromb Res. 2016 May;141:91-2. doi: 10.1016/j.thromres.2016.03.010. Epub 2016 Mar 9. No abstract available.

PMID:
26986754
13.

Comparison of Four Bleeding Risk Scores to Identify Rivaroxaban-treated Patients With Venous Thromboembolism at Low Risk for Major Bleeding.

Kline JA, Jimenez D, Courtney DM, Ianus J, Cao L, Lensing AW, Prins MH, Wells PS.

Acad Emerg Med. 2016 Feb;23(2):144-50. doi: 10.1111/acem.12865. Epub 2016 Jan 14.

14.

Recurrent venous thromboembolism and abnormal uterine bleeding with anticoagulant and hormone therapy use.

Martinelli I, Lensing AW, Middeldorp S, Levi M, Beyer-Westendorf J, van Bellen B, Bounameaux H, Brighton TA, Cohen AT, Trajanovic M, Gebel M, Lam P, Wells PS, Prins MH.

Blood. 2016 Mar 17;127(11):1417-25. doi: 10.1182/blood-2015-08-665927. Epub 2015 Dec 22.

15.

Venous thrombotic burden and the risk of subsequent overt cancer.

Prandoni P, Lensing AW, Prins MH, Villalta S, Negri S, Piccioli A, Noventa F.

Thromb Haemost. 2015 Oct;114(4):864-5. doi: 10.1160/TH15-02-0146. Epub 2015 Jul 9. No abstract available.

PMID:
26155830
16.

Residual vein thrombosis and the risk of subsequent serious complications.

Prandoni P, Lensing AW, Prins MH, Villalta S, Harenberg J, Noventa F.

Thromb Res. 2015 Jul;136(1):178-9. doi: 10.1016/j.thromres.2015.04.038. Epub 2015 May 8. No abstract available.

PMID:
25981139
17.

Oral rivaroxaban for Japanese patients with symptomatic venous thromboembolism - the J-EINSTEIN DVT and PE program.

Yamada N, Hirayama A, Maeda H, Sakagami S, Shikata H, Prins MH, Lensing AW, Kato M, Onuma J, Miyamoto Y, Iekushi K, Kajikawa M.

Thromb J. 2015 Jan 17;13:2. doi: 10.1186/s12959-015-0035-3. eCollection 2015. Erratum in: Thromb J. 2016;14:11.

18.

Treatment of pulmonary embolism with rivaroxaban: outcomes by simplified Pulmonary Embolism Severity Index score from a post hoc analysis of the EINSTEIN PE study.

Fermann GJ, Erkens PM, Prins MH, Wells PS, Pap ÁF, Lensing AW.

Acad Emerg Med. 2015 Mar;22(3):299-307. doi: 10.1111/acem.12615. Epub 2015 Feb 25.

19.

Influence of statin use on the incidence of recurrent venous thromboembolism and major bleeding in patients receiving rivaroxaban or standard anticoagulant therapy.

Wells PS, Gebel M, Prins MH, Davidson BL, Lensing AW.

Thromb J. 2014 Nov 26;12:26. doi: 10.1186/1477-9560-12-26. eCollection 2014.

20.

Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery.

Bedenis R, Lethaby A, Maxwell H, Acosta S, Prins MH.

Cochrane Database Syst Rev. 2015 Feb 19;(2):CD000535. doi: 10.1002/14651858.CD000535.pub3. Review.

PMID:
25695213

Supplemental Content

Loading ...
Support Center